Clinical Trials Browser

Phase 2/3 × Interventional × SR 48692 × Clear all

NCT00290953 2008-12-23

SESAME

Phase 2/3 Completed

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma